Sunday, May 12, 2013

ADHD’s Lasting Effects Prove That Mental Disorders Need To Be Treated Just Like Any Other Illness

When the bipartisan Wellstone-Domenici Mental Health Parity and Addiction Equity Act (MHPAEA) was signed into law in 2008, mental health advocates hoped it would begin bridging the gap between the way that mental health treatments and more “traditional” medical services are provided — particularly by prohibiting different standards for one type of care over the other. Unfortunately, the evidence shows there’s still a long way to go when it comes to making the dream of medical parity a reality.

Time’s new Mayo clinic-sponsored report points out that ADHD, while being increasingly diagnosed and treated in children, has lingering long-term effects on adults and is a strong indicator of co-occurring mental illnesses for both children and adults. But lax insurance requirements, as well as a lack of awareness about the long-term effects of mental illness, have led to a dearth of research regarding the comprehensive effects of what medical professionals tend to dismiss as a childhood behavioral disorder:

It’s not that the condition isn’t being addressed adequately, or that doctors, parents and teachers are not aware of the condition: they certainly are, since education and awareness about ADHD has increased in recent decades, even contributing to a rise in diagnoses… [Dr. Barbaresi of Boston Children’s Hospital and Mayo Clinic] argues, however, that the legacy and long term implications of an ADHD diagnosis haven’t really been considered and studied adequately, since most doctors tend to think of the condition as one that primarily affects children that they tend to outgrow once they reach adulthood. The need for attention is even greater considering that the study also found a connection between ADHD and suicide. While the absolute number of deaths in the adults who still have ADHD is low, the statistical difference is significant: children with ADHD were nearly five times more likely to die from suicide than other people in the study group. [...]

In addition, data from this same group of study participants showed that more than 60% of kids with ADHD have a learning disability and develop at least one additional mental-health problem while they’re still children. Yet insurance companies are reluctant to authorize additional assessments that may detect and treat these conditions. “If a child gets diagnosed with ADHD, we want to do a comprehensive psychological assessment to see if the child has undiagnosed disorders because we know these kids are at risk,” says Barbaresi. “But insurance won’t pay.”

That’s in stark contrast to the way that children are evaluated for other medical conditions, such as diabetes. “We know they’re at risk for developing kidney and eye problems so they’re regularly assessed for those issues. We don’t wait until a child has renal failure or loses his eyesight,” says Barbaresi. “But with childhood ADHD, we can’t get authorization to do these assessments until it’s already happened.”

The Mayo study on ADHD underscores the practical hurdles of enacting true parity between the ways that mental health disorders and more “traditional” medical problems are diagnosed, treated, and even researched. Societal stigmas and decades of traditional medical practice have perpetuated a system in which mental health disorders are considered to be unique, individualistic medical problems — they are not — that ignores the interplay that mental disorders have with other medical conditions, not to mention the physical manifestations of such disorders.

Much of the focus on changing this unacceptable status quo has — justifiably — concentrated on funding and access to mental health care services. For instance, between the Wellstone-Domenici law and Obamacare’s requirement that statewide insurers include mental health coverage as an “essential health benefit,” millions of Americans are expected to gain access to mental services:

That is undoubtedly a step in the right direction. But the mental health benefits that states must provide under Obamacare are left largely to states’ discretion — and there is little reason to expect that states will impose strict requirements on insurers since mental health is still largely considered a form of “specialty” care culturally, if not legally, and private insurance doesn’t tend to cover patients’ out-of-pocket psychiatric costs. Bringing true parity between mental and physical health care necessitates a paradigm shift in the very culture of how such conditions are analyzed, approached, and treated, in addition to stricter insurer requirements for providing comprehensive care.

Armed with more data from longitudinal studies about the long-term effects and complex interactions of mental health problems — such as the Mayo ADHD study — health care professionals could substantially improve the lives of millions of Americans, and help eliminate a dangerous medical inequality and stigma in the process.


View the original article here

Saturday, May 11, 2013

Presidential Proclamation -- 100th Anniversary of the United States Department of Labor

The White House

Office of the Press Secretary

BY THE PRESIDENT OF THE UNITED STATES OF AMERICA

A PROCLAMATION

On March 4, 1913, President William Howard Taft signed a bill establishing the United States Department of Labor -- an agency charged with promoting the welfare of American workers and ensuring their efforts are rewarded with fair wages and real protections. After decades of struggle by labor leaders and ordinary citizens, the Department took up the cause of justice in the workplace and lifted it to the highest halls of government.

Over the course of a century, the Department of Labor has fought to secure strong safeguards for workers and their families. It helped lay the cornerstones of middle class security, from the 40-hour work week and the minimum wage to family leave and pensions. As the agency once led by our Nation's first female Cabinet Secretary, the Department has broken down barriers to equal opportunity in the workplace. And for decades, it has improved worker safety and health and aggressively combated child labor at home and abroad.

Today, the Department of Labor is working to restore the basic bargain that built our country: that no matter what you look like or where you come from, if you work hard and meet your responsibilities, you can get ahead. It is forging new ladders of opportunity so a generation of workers can get the 21st century skills and training they need. And to preserve a century's progress in labor rights, the Department will continue to ensure hardworking Americans always have a voice in government and on the job.

On this centennial, we recognize the dedicated public servants at the Department of Labor who have helped move our country forward, and we reaffirm our commitment to giving America's workers the chance to build a brighter future for themselves and their families.

NOW, THEREFORE, I, BARACK OBAMA, President of the United States of America, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim March 4, 2013, as the 100th Anniversary of the United States Department of Labor. I call upon all Americans to observe this day with appropriate programs, ceremonies, and activities that recognize the United States Department of Labor for upholding dignity in our workplaces and our way of life. ?

IN WITNESS WHEREOF, I have hereunto set my hand this first day of March, in the year of our Lord two thousand thirteen, and of the Independence of the United States of America the two hundred and thirty-seventh.

BARACK OBAMA

Extending Middle Class Tax Cuts

Hanging Out with First Lady Michelle Obama

Mrs. Obama joins a virtual conversation about Let’s Move!, her initiative to ensure our nation’s kids grow up healthy and reach their full potential.

The Open Government Partnership publishes the text of the President's directive extending whistleblower protections to the intelligence and national security communities, as requested by the community.

The Department of Labor celebrates its centennial anniversary and looks forward to continuing its important work on behalf on America's workers.

view all related blog posts

View the original article here

GOP Congresswoman: I Opposed Domestic Violence Bill Because It Protected Too Many Groups

Rep. Marsha Blackburn (R-TN)

Rep. Marsha Blackburn (R-TN) on Monday openly admitted that she opposed the latest reauthorization of the Violence Against Women Act (VAWA) because it included protections for LGBT, Native American, and undocumented victims of domestic violence.

In an appearance on MSNBC, Blackburn pointed out that the latest iteration of the law protects “different groups” and thus dilutes funding for straight, non-Native American women with the proper documentation:

When you start to make this about other things it becomes an “against violence act” and not a targeted focus act… I didn’t like the way it was expanded to include other different groups. What you need is something that is focused specifically to help the shelters and to help out law enforcement, who is trying to work with the crimes that have been committed against women and helping them to stand up.

Watch it:

Domestic violence is domestic violence, period. And there is no way to justify Blackburn’s suggestion that some victims of this violence are more deserving than others. The reauthorized VAWA allows programs targeting LGBT victims of domestic violence to compete on equal footing for grant money with other groups serving underserved populations, and it ensures that LGBT victims will not be turned away from shelters and other services because of their sexual orientation or gender identity. These victims of violence deserve the same protections as anyone else caught in domestic abuse.

Additionally, the reauthorized VAWA includes provisions to prevent serial rapists and similar abusers from preying on Native American women. If Blackburn considers Native American women a “different group,” then it’s one she should be most concerned about: Three out of every five Native American women has been assaulted by an intimate partner.


View the original article here

UPDATE 1-India board rules against Bayer in cancer drug patent case

* Bayer's appeal against licence for generic Nexavar dismissed

* Royalty payment to Bayer raised to 7 pct on Nexavar sales * Natco Pharma fined for presenting incorrect data

(Adds details, background, quotes)

By Anupama Chandrasekaran

CHENNAI, March 4 (Reuters) - An Indian patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines.

The ruling paves the way for the issue of more so-called compulsory licences as governments, particularly in emerging markets such as China and Thailand, battle to bring down healthcare costs and provide access to affordable drugs to treat diseases such as cancer, HIV-AIDS and hepatitis.

Bayer, Germany's largest drugmaker, said it would continue to fight to overturn the decision, which it said weakened the international patent system and endangered pharmaceutical research.

Under a global Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, countries can issue compulsory licences on certain drugs that are deemed unaffordable to a large section of their populations.

India's $13 billion drug market is seen by drugmakers as a huge opportunity, but there are concerns about the level of protection for intellectual property in the country -- where generic medicines account for more than 90 percent of drug sales -- after a series of judicial setbacks for "big pharma".

COMPULSORY LICENCE CHALLENGED

Last year, the Indian patents office allowed Natco Pharma

to sell generic Nexavar at 8,800 rupees ($160) for a month's dose -- a fraction of Bayer's price of 280,000 rupees.

Bayer challenged this decision to grant Natco a compulsory licence at the Intellectual Property Appellate Board (IPAB) in the southern city of Chennai.

On Monday the board dismissed the petition, although it did order Natco Pharma to pay a royalty of 7 percent on sales of generic Nexavar to Bayer, an increase from the 6 percent royalty that had earlier been set.

Also, the board fined Natco Pharma 50,000 rupees for presenting incorrect facts during the legal proceedings. The amount would be donated to a cancer treatment hospital, the board ordered.

Announcing the decision, Justice Prabha Sridevan said the kidney and liver cancer drug should be available at an affordable price to everybody.

Bayer said in a statement it "strongly disagreed" with the conclusions of the board, adding that it would seek to challenge it at the High Court in Mumbai.

"The challenges faced by the Indian healthcare system have little or nothing to do with patents on pharmaceutical products as all products on India's essential drug list are not patented," the company said.

Natco Pharma Company Secretary M. Adinarayana told reporters the board had delivered a "reasoned, detailed" decision that could be "sustained in any court of law".

LEGAL SETBACKS

In a separate case, Bayer has accused another Indian drugmaker, Cipla , of infringing its patent on Nexavar. Cipla had launched its generic version of Nexavar before Natco won the compulsory licence.

Cipla undercut Natco's price in May last year and now sells the drug at 6,840 rupees for a month's dose.

Among other setbacks for Western drug companies, India has revoked patents granted to Pfizer Inc's cancer drug Sutent, Roche Holding AG's hepatitis C drug Pegasys and Merck & Co's asthma treatment aerosol suspension formulation.

Another case involving drug patents is currently in front of the Supreme Court, with Novartis battling against an earlier decision refusing it a patent on cancer drug Glivec.

New Delhi has also taken other measures, such as controlling the prices of generic medicines and providing free medicines at government-run hospitals that cater to the country's poor.

Last week a government panel recommended a formula to curb prices of patented drugs to make them affordable for the world's second-most populous country.

($1 = 54.90 rupees)

(Additional reporting and writing by Kaustubh Kulkarni in MUMBAI; Editing by Alex Richardson)

((kaustubh.kulkarni@thomsonreuters.com)(+91 22 61807399)(Reuters Messaging: kaustubh.kulkarni.thomsonreuters.com@reuters.net))

Keywords: INDIA BAYER/


View the original article here

Presidential Proclamation -- American Red Cross Month, 2013

The White House

Office of the Press Secretary

AMERICAN RED CROSS MONTH, 2013

- - - - - - -

BY THE PRESIDENT OF THE UNITED STATES OF AMERICA

A PROCLAMATION

Since our Nation's founding, seasons of trial and bitter hardship have revealed a core belief we share as Americans: that when we see our neighbors in need, we will always stand united in helping them get back on their feet. This month, we honor men and women who deliver relief to communities around the world, and we renew the compassionate spirit that continues to keep our country strong and our people safe.

The American Red Cross has proudly upheld a commitment to service that spans generations. Witness to the scars left by civil war, Clara Barton founded the organization in 1881 as a way to lift up the suffering -- from warriors wounded in the line of duty to families displaced by damaging storms. In the years since, countless service and relief organizations have joined the American Red Cross in realizing that noble vision.

We saw the depth of their dedication just 4 months ago, when the sweeping devastation of Hurricane Sandy put millions of Americans in harm's way. In darkness and danger, thousands of professionals and volunteers stepped up to serve. They secured supplies and shelter when our people needed them most. And when times were tough, they proved that America is tougher because we all pull together.

That sense of resolve has seen our Nation through our greatest challenges, and the conviction that we are our brothers' and sisters' keepers will always remain at the heart of who we are as a people. As we reflect on the ties that bind us together, let us pay tribute to humanitarian organizations working here at home and around the world, and let us rededicate ourselves to service in the months ahead.

NOW, THEREFORE, I, BARACK OBAMA, President of the United States of America and Honorary Chairman of the American Red Cross, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim March 2013 as American Red Cross Month. I encourage all Americans to observe this month with appropriate programs, ceremonies, and activities, and by supporting the work of service and relief organizations.

IN WITNESS WHEREOF, I have hereunto set my hand this twenty-eighth day of February, in the year of our Lord two thousand thirteen, and of the Independence of the United States of America the two hundred and thirty-seventh.

BARACK OBAMA

Extending Middle Class Tax Cuts

Hanging Out with First Lady Michelle Obama

Mrs. Obama joins a virtual conversation about Let’s Move!, her initiative to ensure our nation’s kids grow up healthy and reach their full potential.

The Open Government Partnership publishes the text of the President's directive extending whistleblower protections to the intelligence and national security communities, as requested by the community.

The Department of Labor celebrates its centennial anniversary and looks forward to continuing its important work on behalf on America's workers.

view all related blog posts

View the original article here

India rules against Bayer in cancer drug patent case

CHENNAI, March 4 (Reuters) - An Indian patent appeals board dismissed on Monday Bayer AG's petition against a government decision to allow a domestic company to sell cheap copycat versions of cancer drug Nexavar, delivering a blow to global drugmakers' monopolies on high-priced medicines.

Last year, the Indian patents office, under a mechanism called "compulsory licence", allowed Natco Pharma to sell generic Nexavar at 8,800 rupees ($160) for a month's dose -- a fraction of Bayer's price of 280,000 rupees.

Bayer challenged this decision with the Intellectual Property Appellate Board (IPAB) in the southern city of Chennai.

Although dismissing the petition, the board did order Natco Pharma to pay a royalty of 7 percent on sales of generic Nexavar to Bayer, an increase from the 6 percent royalty that had earlier been set.

($1 = 54.90 rupees)

(Reporting by Anupama Chandrasekaran; Editing by Alex Richardson)

((kaustubh.kulkarni@thomsonreuters.com)(+91 22 61807399)(Reuters Messaging: kaustubh.kulkarni.thomsonreuters.com@reuters.net))

Keywords: INDIA BAYER/


View the original article here

Why New York City’s Effort To Shame Teens Is The Wrong Way To Promote Sexual Health

So far, New York City’s campaign to prevent unintended teen pregnancy has been extremely successful. The public schools in the city have instituted a mandatory comprehensive sex ed curriculum, as well as a program to help expand teen’s access to contraception — both of which have directly contributed to the fact that the teen pregnancy rate in New York City has plummeted by 27 percent over the past decade.

The city’s Human Resources Administration is now expanding those efforts to a broader marketing campaign, rolling out a series of advertisements that intend to communicate the “real cost of teen pregnancy.” The ads, which will appear on subways and bus shelters across the city, are an attempt to frighten teens out of having a child at a young age:

This strategy may not be totally without precedent. Wonkblog’s Sarah Kliff points out that a similar type of advertising campaign in Milwaukee helped contribute to a drop in teen pregnancies. But the huge drop that New York City has already seen over the past 10 years belies a simple fact: edgy advertising isn’t nearly as important as actually equipping young people with the resources they need to understand their bodies and mitigate their sexual risk.

In fact, a recent study demonstrates that providing young adults with the support they need can be a more effective method of preventing unwanted pregnancies than shaming teens about their sexuality. Throughout the course of the study, the teens that participated in a program tailored to help young people make good sexual choices — including providing providing personal case management, youth leadership opportunities, and specialized counseling — were much more likely to make safe sexual choices, like using condoms, than the teens who weren’t in that program. And the healthy sexual behavior extended beyond simply using protection. The teens who received support and counseling were also more likely to be able to recognize unwanted sexual attention, and refute those type of advances — in other words, they became better aware of their physical boundaries and their ability to withhold consent.

Ultimately, the United States needs a huge overhaul when it comes to society’s approach to teen sexuality. Too often, teens aren’t given accurate information about their bodies, aren’t empowered to make their own decisions, don’t know what “consent” is and how to navigate it, and are ultimately too ashamed to ask for the resources they need. Young adults need to be trusted with information about sexuality — and those who are at a higher risk for unintended pregnancy need to be supported, not stigmatized for the “failures” that result from their sexual behavior.


View the original article here